← Leaderboards
Daniel G Gioeli
University Of Virginia
$4,074,968
Attributed
$4,953,623
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $664.1K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,953,623 · 4
By mechanism
R01$4,542,913 · 3
R21$410,710 · 1
Top collaborators
- John Hackett Bushweller2 shared
- Michael Hageman2 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Sidney M. Hecht$9,031,231
- John Hackett Bushweller$17,127,098
- Chad S Dodson$241,360
- Hudson Golino$241,360
- Michael Hageman$439,328
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoGrowthMalignant Neoplasm Of ProstateAndrogen ReceptorGenesCell CycleIn VitroAndrogensMolecularPhosphotransferasesRegulationInsightSignal TransductionCastrationProstatic NeoplasmsResistanceEventPhosphorylationEffective TherapyMutationReceptor FunctionSignaling MoleculeCdc2 Protein KinaseTumor Progression
Grant awards (13)
Small Molecule ERG Inhibitors for Prostate Cancer$664,086
R01 · FY2025 · CA
Small Molecule ERG Inhibitors for Prostate Cancer$653,897
R01 · FY2024 · CA
HULLK, a novel lncRNA that functions as a targetable oncogene in PCa$410,710
R21 · FY2021 · CA · contact PI
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer$327,850
R01 · FY2018 · CA · contact PI
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer$327,850
R01 · FY2017 · CA · contact PI
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer$327,850
R01 · FY2016 · CA · contact PI
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer$327,850
R01 · FY2015 · CA · contact PI
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer$327,850
R01 · FY2014 · CA · contact PI
Role of Androgen Receptor Phosphorylation in Prostate Cancer$304,080
R01 · FY2012 · CA · contact PI
Role of Androgen Receptor Phosphorylation in Prostate Cancer$304,099
R01 · FY2011 · CA · contact PI
Role of Androgen Receptor Phosphorylation in Prostate Cancer$313,524
R01 · FY2010 · CA · contact PI
Role of Androgen Receptor Phosphorylation in Prostate Cancer$343,098
R01 · FY2009 · CA · contact PI
Role of Androgen Receptor Phosphorylation in Prostate Cancer$320,879
R01 · FY2008 · CA · contact PI